In-vitro assessment of differential cytokine gene expression in response to infections with Egyptian classic and variant strains of highly pathogenic H5N1 avian influenza virus  by Samy, A.A. et al.
International Journal of Veterinary Science and Medicine (2015) 3, 1–8HO ST E D  BY
Cairo University
International Journal of Veterinary Science and Medicine
www.vet.cu.edu.eg
www.sciencedirect.comFull Length ArticleIn-vitro assessment of diﬀerential cytokine gene
expression in response to infections with Egyptian
classic and variant strains of highly pathogenic
H5N1 avian inﬂuenza virus* Corresponding author. Tel.: +20 002 01147449758; fax: +20 002
33370957.
E-mail address: dr.ahmed189@gmail.com (A.A. Samy).
Peer review under responsibility of Faculty of Veterinary Medicine,
Cairo University.
http://dx.doi.org/10.1016/j.ijvsm.2015.01.001
2314-4599 ª 2015 Faculty of Veterinary Medicine, Cairo University. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).A.A. Samy a,*, M.I. El-Enbaawy b, A.A. El-Sanousi c, S.A. Abd El-Wanes a,
A.M. Ammar d, H. Hikono e, T. Saito ea Reference Laboratory for Veterinary Quality Control on Poultry Production, Animal Health Research Institute,
Dokki, Giza 12618, Egypt
b Microbiology Department, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt
c Virology Department, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt
d Microbiology Department, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt
e Inﬂuenza and Prion Disease Research Centre, National Institute of Animal Health, National Agriculture
and Food Research Organization (NARO), Kannondai, Tsukuba, Ibaraki 305-0856, JapanReceived 9 August 2014; revised 30 January 2015; accepted 31 January 2015






InterleukinAbstract In Egypt, two distinct genetic groups of HPAI H5N1 viruses are co-circulating: classic
2.2.1/C sub-clade and antigenic drift variant 2.2.1.1 clade isolated from vaccinated poultry ﬂocks.
The response of chicken innate immunity to both genotypes is not investigated, so far. In this study,
expression of immune related genes (IL1b, IL4, IL6, IL8, IL10, IL18, IFNa and IFNc) after infect-
ing chicken macrophage cell line (HD11) and chicken peripheral blood Mononuclear cells (PBMC)
with a classic and a variant strains was assayed using quantitative reverse-transcription real-time
polymerase chain reaction assays (qRT-PCR). In HD11, the variant strain induced higher levels
of IL1b and IL8 at 6 hours post infection (hpi), IL4 at 24 / 48 hpi and IFNa at 48 hpi than the
classic strain. Conversely, the classic strain induced about 10-fold increase of IFNc at 24 and
48 hpi and the virus replicated at higher level than the variant strain. The results of PBMC infection
were similar to that reported from HD11 except for IFNc gene expression that was higher at variant
strain infected cells than that infected with the classic strain. After 24hpi skewing the innate immune
response toward anti-inﬂammatory (humoral-associated) cytokines was different between HD11
(through IL4) and PBMC (through IL10). To sum up, the classic strain produced less cytokines
2 A.A. Samy et al.which may indicate adaptation to evade the recognition by the innate immune system and explain
its higher pathogenicity.
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open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Highly pathogenic avian inﬂuenza virus subtype H5N1
(HPAIV H5N1) is a worldwide devastating disease of poultry,
which presents a potential pandemic threat [1]. Since its
emergence in 1997 in Hong Kong, the virus spread to more
than 60 countries and ﬁnally became endemic in poultry
populations at Bangladesh, China, Egypt, Indonesia and Viet
Nam [2]. In case of Egypt, losses in poultry industry since
2006 was estimated to exceed $1 billion due to culling or death
of over 30 million birds [3]. According to the WHO, the virus
was spilled over to 173 persons and caused deaths in 63
patients by the 26th of November, 2013 [4]. Vaccination of
commercial poultry against the HPAIV H5N1 using different
H5 vaccines was a milestone in the control of the disease in
Egypt. The reduced number of outbreaks after the ﬁrst wave
in 2006 in poultry was attributed to the effectiveness of these
vaccines to interrupt the circulation of the virus particularly
in the commercial sector [3]. Since 2007, a dramatic increase
in the number of infected ﬂocks despite vaccination was
reported [5].
Phylogenetic analyses of the Egyptian H5N1 viruses indi-
cated co-circulation of two distinct genetic groups. The ﬁrst
group belongs to the 2.2.1/C subclade, also known as classic
group, is very close to the predecessor 2.2.1 viruses introduced
into Egypt in early 2006. These viruses were isolated from
non-vaccinated backyard birds as well as from human [6].
They were also able to induce clinical disease and mortality
in improperly vaccinated chickens in small-scale commercial
farms [7]. The second genetic group classiﬁed separately in a
unique 2.2.1.1 clade. Viruses in this clade represent the
antigenic drift variants isolated from vaccinated birds and
harbour major changes in immunogenic epitopes of the
hemagglutinin (HA) protein [6]. Experimental challenge
studies showed that the classic group caused mild clinical signs
in chickens vaccinated with homologous or heterologous H5
vaccines; however it was excreted for long periods of time.
On the contrary, the variant strains caused up to 100% mortal-
ity in chickens vaccinated with heterologous vaccines and virus
excretion was limited in birds vaccinated with homologous
H5N1 vaccines [8]. Accordingly, since 2011 no variant virus
was isolated and the classic strains are the predominant geno-
type in Egypt due to probably adoption of more genetically
related homologous vaccines in the commercial poultry [6].
Much emphasis has been placed on the humoral immunity
but the response of innate immune system of chickens to infec-
tions with H5N1 strains has not been adequately studied [9].
The current dogma of the immunology states that the innate
immune response is the ﬁrst line of defence of a host against
microbial invasion [10]. An essential component of the innate
immune system is cytokines which are triggered upon stimula-
tion of host-cells with a micro-organism. They orchestrate
innate and adaptive antiviral defence mechanisms to eliminate
(e.g. inﬂuenza virus) infections from the host [11]. According
to their function, three classes of cytokines are mostlyimportant (1) proinﬂammatory cytokines such as interleukin-
1b (IL-1b), Interleukin-6 (IL6), IL8 and tumour necrosis
factor-a (TNF-a) that play a role in the induction of inﬂamma-
tion during the course of infection, (2) T-Helper 1 (Th1) asso-
ciated cytokines including IL18 and IFNc that regulate and
induce cell mediated immune (CMI) response and (3) anti-
inﬂammatory/Th2 cytokines like IL4 and IL10 that involved
in the induction and regulation of humoral immune response
[9]. In comparison to mammals, repertoire of cytokines in
chicken was not fully understood until recently. A considerable
number of chicken immune-related molecule orthologs have
been identiﬁed and quantiﬁcation of cytokine messenger
RNA (mRNA) expression levels using quantitative real-time
reverse-transcription polymerase chain reaction (qRT-PCR)
improved our knowledge on the host-virus interaction [12].
In human or mammal models, extensive literatures have been
published on the molecular viral mechanisms involved in
the H5N1 pathogenesis [13] but very little is known about
the host-inﬂuenza-interaction in chickens particularly the
regulation of the innate immune response by HPAIV H5N1
immune-escape variants.
In the present study, HD11cell line and chicken PBMCs
were used to study the regulation of cytokines upon infections
with a classic and a variant HPAI strains isolated from chick-
ens in Egypt.2. Materials and methods
2.1. H5N1 strains propagation
Two viruses were obtained from the inﬂuenza virus repository
of the Reference Laboratory for Quality Control on Poultry
Production (RLQP), Egypt. A/chicken/Egypt/0963S-NLQ
P/2009(H5N1), GenBank accession number HQ198269
belongs to the variant 2.2.1.1 clade and A/chicken/ Egypt/
121/2012(H5N1), GenBank accession number JQ858483
belongs to the classic 2.2.1/C subclade. Both viruses were
propagated in 9 day-old speciﬁc pathogen free embryonated
chicken eggs according to the standard protocol [14]. All
procedures were performed in BSL3 laboratory facilities at
the National Institute of Animal Health (NIAH), Japan. Viral
titters were expressed as mean tissue culture infectious dose
(TCID50) using HD11 cell line for each strain according to
Reed and Muench [15].
2.2. HD11 cell line propagation and infection
HD11 cells were kindly provided by Dr. John Adams (the
Cedars-Sinai Medical Centre, Los Angeles, CA, USA). Cell
were counted and diluted in 2 mL growth media per well of
6-well plates to get 1.5·106 cell per well and incubated for
24 hrs to form a conﬂuent sheet. After 24 hrs the media were
removed and cells were washed with PBS. Cells were collected
from one well of 6 well plate with trypsin and were counted to
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infection media contain the ﬁltered viral allantoic ﬂuid
(0.05TCI50/cell) were added to every well and incubated for
1 hour with gently shaking every 15 min then the media was
removed and cells were washed with PBS followed by addition
of 2 mL of MEMmedium (Gibco; Carlsbad, CA, USA). Plates
were incubated at 37 C in 5% CO2 incubator. HD11 cultures
were used in parallel without the addition of viral allantoic
ﬂuid (VAF) as negative control. Samples (cells and super-
natant) were collected at 6, 24 and 48 hr post infection (hpi)
for RNA extraction as described below.
2.3. PBMC isolation, culturing and infection
Heparinized blood was collected form 10 week-old chickens
and mixed with equal volume of PBS, then layered drop by
drop over equal volume of Ficoll-Paque (GE health care,
Sweden) followed by centrifugation at 400·g for 30 min with-
out brake. PBMC were removed at the mononuclear cell inter-
face carefully and washed twice with PBS and then subjected
to centrifugation at 100·g for 10 min. The resultant pellet
was re-suspended in complete RPMI media (Gibco, Carlsbad,
CA, USA) containing 10% FBS. PBMC were grown overnight
at cell density 107 per well of 12-well tissue culture plates and
incubated at 37 C in 5% CO2 incubator. After overnight
growth, non-adherent cells were removed by washing the
monolayers with PBS to enrich the cultures for adherent
macrophages, monocytes and dendritic cells. One PBMC
culture was trypsinized and the cells were counted to calculate
the required amount of VAF to get infection dose of
0.05TCID50/cell. Growth media was replaced with infection
media containing complete RPMI but without serum and with
the addition of ﬁltered VAF. Negative control PBMC cultures
without the addition of VAF were incubated in parallel.
Culture plates were gently shaken every 15 min for 1 hr then
the media was replaced with RPMI supplemented with 0.2%
FBS. Cultures were incubated at 5% CO2 and RNA was
extracted from the cell monolayer and supernatant at 6, 24,
and 48hpi.
2.4. Total RNA extraction
Total RNA was isolated from infected and control HD11
and PBMC cells and supernatant at each time point using
RNeasy mini RNA Puriﬁcation kit and DNase treatment
with QIAGEN RNA puriﬁcation kits to purify RNA
from DNA contamination following manufacturer’s instruc-
tions (Qiagen Inc., Valencia, CA, USA). RNA in each sample
was quantiﬁed Using NanoDrop-1000 (Thermoscientiﬁc,
Wilmington, DE).2.5. qRT-PCR
qRT-PCR was performed using Quantitect probe RT-PCR
(Qiagen, Inc. Valencia, CA, USA) according to the manufac-
turer recommendations. Primers and probes were selected for
ampliﬁcation of IL1b, IL6 and IFNc [16], IL4 and IL10 [17],
IL8 and IL18 [18], and IFNa [19] as shown in Table 1.
qRT-PCR runs were performed using 7500 Real-Time PCR
System (Applied Biosystems, Foster City, CA, USA). PCRconditions were the same for each targeted gene of different
cytokines as follows: 30 min at 50 C, 95 C for 15min,
followed by 40 cycles of 95 C for 15 s, 60 C for 1min. For
detection of AIV H5 [20], the thermoproﬁle was 30 min at
50 C, 95 C for 15 min, followed by 40 cycles of 95 C for
10 s, 54 C for 30 s and 72 C for 30 sec.
Absolute quantiﬁcation for viral RNA was calculated using
tenfold-serially diluted RNA from known TCID50 classic and
variant strains. The standard curves were created automati-
cally by plotting the threshold level of ﬂuorescence (Ct values)
against the TCID50 for every dilution. The Ct values of the
unknown samples were then compared to the Ct values of
the standards. The starting template quantities for the
unknown samples could be estimated in the present study
using standard curve generated with every PCR run. For rela-
tive quantiﬁcation of cytokines mRNA, ampliﬁcation data of
cytokines were normalized against 28s RNA [16] and fold
change of cytokines mRNA gene expression of infected cells
compared to non-treated cells was calculated as previously
published [21].3. Results
3.1. Virus titration
Serial titrations of both viral strains were performed in HD11
cell line and TCID50 titres were determined. The titer of the
variant strain was calculated as 4·106.4 TCID50/mL while
the classic strain was 4·105.6 TCID50/mL. The variant strain
grew at lower levels than the classic strain in HD11 at all-
time points reaching 105.5 and 106.8 TCID50/mL at 48 hpi for
the variant and classic strains, respectively (data not shown).
While in PBMCs, both viruses grew at similar TCID50 levels
at different time point (data not shown).
3.2. Cytokines mRNA gene expression using HD11 cell line
(Table 2)
Cytokines mRNA gene response was detected at 6, 24 and
48 hpi after infection using qRT-PCR (Fig. 1). The pro-
inﬂammatory cytokines IL1b and IL8 were expressed at high
levels and early at 6 hpi, while expression of IL4 and IFNc
increased later at 24 and 48 hpi compared with the non-
infected cells. At 6 hpi, the variant strain increased the IL8,
IL1b, IL4 and IL10 expression levels by 6.5, 4.2, 1.1 and 1.0-
fold, respectively compared to those levels induced by the clas-
sic strain. Likewise, higher folds of about 1.0 and 7.1 at 24 hpi
and 3.9 and 5.7 at 48 hpi for IL1b and IL4, respectively were
obtained by the variant strains. Conversely, at 24 and 48 hpi
about 18.0 and 14.0 higher folds of IFNc respectively were
induced by the classic strains than those obtained by the vari-
ant strain. IFNa gene expression levels were increased only at
48 hpi by the variant strain infected cells while other cytokines
showed no marked changes (Fig. 1).
3.3. Cytokines mRNA gene expression using PBMC cell culture
(Table 3)
The level of cytokines mRNA gene expression markedly
upregulated by both strains at each time point particularly
Table 1 Sequences of the primers and probes used in quantitative qRT-PCR.
Gene Name Sequence (50–30) Refs.
IL1B F-Primer GCTCTACATGTCGTGTGTGATGAG Kaiser et al. [16]
R-Primer TGTCGATGTCCCGCATGA
Probe F AM-CCACACTGCAGCTGGAGGAAGCC-(TAMRA)
IL4 F-Primer AACATGCGTCAGCTCCTGAAT Kumar et al. [17]
R-Primer TCTGCTAGGAACTTCTCCATTGAA
Probe FAM-AGCAGCACCTCCCTCAAGGCACC-TAMRA
IL6 F-Primer GCTCGCCGGCTTCGA Kaiser et al. [16]
R-Primer GGTAGGTCTGAAAGGCGAACAG
Probe FAM-AGGAGAAATGCCTGACGAAGCTCTCCA-TAMRA
IL8 F-Primer GCCCTCCTCCTGGTTTCA G Kogut et al. [18]
R-Primer TGGCACCGCAGCTCATT
Probe FAM-TCTTTACCAGCGTCCTACCTTGCGACA-TAMRA
IL10 F-Primer CATGCTGCTGGGCCTGAA Kumar et al. [17]
R-Primer CGTCTCCTTGATCTGCTTGATG
Probe FAM-CGACGATGCGGCGCTGTCA-TAMRA
IL18 F-Primer AGGTGAAATCTGGCAGTGGAAT Kogut et al. [18]
R-Primer ACCTGGACGCTGAATGCAA
Probe FAM-CCGCGCCTTCAGCAGGGATG-TAMRA
IFNa F-Primer GACAGCCAACGCCAAAGC Eldaghayes et al. [19]
R-Primer GTCGCTGCTGTCCAAGCATT
Probe FAM-CTCAACCGGATCCACCGCTACACC-TAMRA
IFNc F-Primer GTGAAGAAGGTGAAAGATATCATGGA Kaiser et al. [16]
R-Primer GCTTTGCGCTGGATTCTCA
Probe FAM-TGGCCAAGCTCCCGATGAACGA-TAMRA
28S F-Primer GGCGAAGCCAGAGGAAACT Kaiser et al. [16]
R-Primer GACGACCGATTTGCACGTC
Probe FAM-AGGACCGCTACGGACCTCCACCA-TAMRA
AIV (H5) LH1-Primer ACATATGACTACCCACARTATTCAG Slomka et al. [20]
RH1-Primer AGACCAGCTAYCATGATTGC
Probe FAM-TCWACAGTGGCGAGTTCCCTAGCA-TAMRA
Table 2 Cytokines mRNA fold change at 6, 24 and 48 h after infection of HD11 cell line with 0.05 TCID50 per cell.
Cytokines 6 h 24 h 48 h
Classical Variant Classical Variant Classical Variant
IL1b 23.96405 28.12147 1.261552 2.211308 1.198143 5.088005
IL4 1.3297 2.39197 13.8864 21.0303 20.8171 26.4904
IL6 1.11891 1.2886 1.30279 0.99481 1.20497 1.88296
IL8 4.63992 11.1255 0.48609 0.55826 0.51939 0.82599
IL10 1.32648 2.25793 0.29968 0.26521 0.07471 0.14839
IL18 2.90291 2.46844 0.42647 0.14876 0.35792 0.18233
IFNc 2.61389 3.52079 26.5309 8.56112 22.4773 8.5185
IFNa 1.07482 1.00292 0.95754 0.94606 1.91906 3.24204
Table 3 Cytokines mRNA fold change at 6, 24 and 48 h after infection of PBMC with 0.05 TCID50 per cell.
6 h after infection 24 h after infection 48 h after infection
Classical Variant Classical Variant Classical Variant
IL1b 63.3819 111.4691 9.1883 20.8157 4.0424 21.6111
IL4 2.8036 1.2879 0.9764 3.1199 1.1037 3.0111
IL6 184.3879 506.8096 13.5226 24.804 12.4416 12.4554
IL8 219.4274 136.5232 34.0386 30.6009 10.1944 35.8152
IL10 4.5732 84.4368 4.1592 70.3608 3.5373 26.3768
IL18 2.6036 5.1437 1.0786 1.0449 0.3396 0.4444
IFNc 4.5732 84.4368 0.6596 5.6859 2.0669 6.7473
IFNa 0.4411 1.1423 0.4180 1.7633 0.2595 0.8520
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Fig. 1 Cytokines mRNA fold change at 6, 24 and 48 h post infection (hpi) of HD11 cell line with Egyptian H5N1 variant (A/chicken/
Egypt/0963S-NLQP/2009) and classical (A/chicken/Egypt/121/2012) strains. mRNAs of IL1b, IL6, IL8, IL4, IL10, IFNc and IFNa were
measured by qRT-PCR in HD11 infected cells. Data show fold change compared with uninfected control HD11 cells. Data represent the
mean; error bars show SE.
In-vitro assessment of differential cytokine gene expression in response to infections 5IL1b, IL6 and IL8 at 6 hpi (Fig. 2). The variant strain at 6hpi
elicited 48.1 to 322.4 folds higher of the IL1b, IL6, IL10 and
IFNc than the classic strain. Conversely, at 6 hpi the classic
strain elicited 1.5 and 82.9 folds of IL4 and IL8, respectively
higher than the variant strain. At 24hpi and 48hpi, higher
levels of expression of most of cytokines induced by the variant
strain than those induced by the classic strain were observed
(Fig. 2). IL8 showed higher mRNA gene expression after infec-
tion of PBMC with the classical strain than that infected with
variant strain at 6 hpi but at 48 hpi the variant strain infected
PBMC showed higher IL8 mRNA gene expression (Fig. 2).
PBMC infected with the variant strain showed marked higher
IFNc mRNA gene expression than that infected with the clas-
sic strain. The classic strain did not regulate IFNamRNA geneexpression similar to the negative control cells but infected
PBMC with the variant strain was slightly upregulated (Fig. 2).4. Discussion
Virulence of HPAIV H5N1 can be modulated by the virus-
host immune system interaction [22,23]. Innate immune
responses via interferon and other cytokines can limit or elim-
inate inﬂuenza virus infections. Variations of cytokines expres-
sion’ pattern between inﬂuenza virus serotypes (e.g. H5N1 and
H1N1) [24] or even within the same subtype (e.g. H5N1 of wild
bird vs. of chickens origins) were intensively elucidated in sev-
eral literatures [12]. Macrophages are an important cellular
Fig. 2 Cytokines mRNA fold change at 6, 24 and 48 h post infection (hpi) of PBMC cell line with Egyptian H5N1 variant (A/chicken/
Egypt/0963S-NLQP/2009) and classical (A/chicken/Egypt/121/2012) strains. mRNAs of IL1b, IL6, IL8, IL4, IL10, IFNc and IFNa were
measured by qRT-PCR in PBMC infected cells. Data show fold change compared with uninfected control PBMC cells. Data represent the
mean; error bars show SE.
6 A.A. Samy et al.component of the immune system and play a primary role in
the development of both innate and adaptive immune
responses. The use of chicken macrophage cells is an optimal
system to study the interaction between HPAIV H5N1 and
the immune system of birds, nevertheless only limited numbers
of studies have been published [25].
In this study, in HD11 cell line both virus genotypes up-
regulated the expression level of cytokines, particularly at
6 hpi, compared to the negative control cells. At early stage
of infection (6hpi) expression levels of the pro-inﬂammatory
cytokines IL1b and IL8 were remarkably increased, but at
later stages of infection (24 and 48hpi) the IL4 and IFNc levels
were the highest, while IFNa expression showed no marked
change at early stage. Such results coincide with that of
Watanabe et al. [26] who recorded up-regulation of IL1b,
IL8, IFNc and IL18 in HD11 cell line infected with an HPAIVH5N1 [27]. Also, low expression of IFNa was correlated with
high viral titre and prolonged shedding time in chickens [28].
Different expression patterns between both viruses were
observed. Generally, the variant strain elicited higher IL1b,
IL4, IL8 and IFNa but the classic strain induced higher IFNc.
This may explain the low replication titter of the variant strain
in HD11and the positive correlation between viral titre and
IFNc expression recorded in vitro [29]. These data support
the ﬁeld observation of the higher virulence of classical strain
comparing to variant strain. As the variant strain induced
higher innate immune response that represented by higher
IL1b,IL8 and IFNa and the immunity skewed toward humeral
immune response represented by IL4 that can efﬁciently reduce
the pathogenicity of the virus and its titre, while classical strain
induced lower innate immunity with higher IFNc that corre-
lated with higher viral titre. These ﬁnding agree with that of
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inﬂammatory response of human macrophages to infection with
low pathogenic virus than highly pathogenic avian inﬂuenza.
Avian species have a similar but not identical network of
macrophages and dendritic cells (DC) to mammalian counter-
part that was involved in uptake of foreign antigens [29]. In
PBMC, results of cytokines mRNA gene expression revealed
that most of tested cytokines markedly elevated early at 6 hpi.
That is expected because dendritic cells compared to other anti-
gen presenting cells (macrophage and B cells) can effectively
capture and process antigens, express higher level of MHC
and co-stimulatory molecules on their surface and also activate
naı¨ve T cells [30]. The results of PBMC infection almost equal to
that reported from HD11 except for IFNc gene expression that
is higher at variant strain infected cells than that infected with
classic strain; nonetheless both viruses grew at a similar level
in PBMC. Inmammals, the IL4 and IL10 play an important role
in the promotion of Th2 responses (humoral immune response)
and inhibition of the proinﬂammatory and Th1 response [31].
This study indicated that after 24hpi skewing toward humoral
immune response is essential and differs in HD11 (through
IL4) and PBMC (through IL10) that was better marked with
variant strain comparing to classical strain.Different expression
levels of cytokines between HD11 were previously observed
using two different pathotypes of H5N1 [26]. It is worth men-
tioning that immune response to HPAIV H5N1 varies accord-
ing the gene constellation of the virus [26] and both Egyptian
genotypes have speciﬁc genetic markers in all gene segments
including the NS1 [6] which is known to be the major viral
host-immune system regulator. Thus, the role of internal pro-
teins on different patterns of cytokine expression elicited by both
strains in this study should be further elucidated. Generally,
innate immune response differs after infection with low patho-
genic AIV (LPAIV) and HPAIV [26]. Friesenhagen et al. [32]
found that LPAIV induced stronger inﬂammatory responses
in human macrophages than HPAIV which may facilitate wide
spread and systemic progression of the later. From various ﬁeld
observations (non published data) variant strain induced lower
pathogenicity and delayed onset of death in infected chicken
comparing to classical strain infection. Here we investigate the
difference in host immune response at the level of immune cells
to both strains. Our data revealed that higher innate immune
response (IL1b,IL6,IL8 and IFNa) with variant strain infec-
tions compared to classical strain infection. These results
explain the lower pathogenicity recorded for variant strain
may be due to efﬁcient higher innate immune response that in
turn skewed to higher humeral immune response (IL4
and IL10). Such mechanism can reduce the variant strain
pathogenicity compared to classical strain infection.5. Conclusion
In conclusion, the immune-escape HPAIV H5N1 elicited
higher innate immune response than the ‘‘classic’’ virus. We
propose that the capability of the variant virus to induced sev-
ere morbidity and mortality among poultry populations across
Egypt is probably due to its ability to escape immune response
elucidated by vaccination due to antigenic variation. Such
variation is thought to affect its epitopes while triggering of
higher innate immune response which do not play a signiﬁcantrole in this case. The classic strain produced less cytokine
(in magnitudes and types) and it was able to replicate to high
titter in HD11 and PMBC, which may indicate adaptation to
evade the recognition by the innate immune system in case
of infection. Ultimately, there will be two queries in a real need
to be investigated; the in-vivo expression of cytokines and the
immunogenicity / pathogenicity of the variant strain compared
to the classic strain.
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